Global Pharmacovigilance and Drug Safety Software Market Report 2023: Increasing Incidence of Adverse Drug Reactions Drives Growth
DUBLIN, May 31, 2023 /PRNewswire/ -- The "Global Pharmacovigilance and Drug Safety Software Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.
The value of the global pharmacovigilance and drug safety software market was USD 7.80 billion in 2022, driven by the increasing incidence of adverse drug reactions across the globe. The market value is anticipated to grow at a CAGR of 8.98% during the forecast period of 2023-2031 to reach a value of USD 16.90 billion by 2031.
It helps in ensuring the safety and efficacy of drugs, improving patient outcomes, and complying with regulatory requirements. The software can also generate reports and alerts based on the analysed data, enabling healthcare professionals and regulators to take informed decisions about the use of drugs.
Overall, pharmacovigilance and drug safety software are critical tools for ensuring the safety and efficacy of drugs and medications, and are used throughout the healthcare industry to improve patient safety and outcomes.
Market Brakup by Mode of Delivery
Market Breakup by End User
Market Breakup by Region
Middle East and Africa
Global Pharmacovigilance and Drug Safety Software Market Scenario
Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/r/gz0i6d
Research and Markets
For E.S.T Office Hours Call +1-917-300-0470
U.S. Fax: 646-607-1907
View original content:https://www.prnewswire.com/news-releases/global-pharmacovigilance-and-drug-safety-software-market-report-2023-increasing-incidence-of-adverse-drug-reactions-drives-growth-301838462.html
SOURCE Research and Markets
UCaaS and MSPs: Driving Collaboration, Productivity, and Customer Experience
Registration Counters Open